Global IL-23p19 Inhibitors Market Growth 2026-2032
The global IL-23p19 Inhibitors market size is predicted to grow from US$ 20030 million in 2025 to US$ 56880 million in 2032; it is expected to grow at a CAGR of 16.4% from 2026 to 2032.
IL-23p19 inhibitors are a class of drugs that work by inhibiting the biological activity of Interleukin-23 (IL-23). IL-23 is a cytokine composed of two subunits, p40 and p19, of which p19 is the specific subunit of IL-23?The mechanism of action of IL-23p19 inhibitors is to prevent IL-23 from binding to its receptor by specifically binding to the p19 subunit of IL-23, thereby disrupting IL-23-mediated signaling pathways and reducing the production of inflammatory factors, such as IL-17, IL-22 and GM-CSF. These factors play an important role in chronic inflammatory diseases.
United States market for IL-23p19 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IL-23p19 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IL-23p19 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IL-23p19 Inhibitors players cover Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?IL-23p19 Inhibitors Industry Forecast? looks at past sales and reviews total world IL-23p19 Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected IL-23p19 Inhibitors sales for 2026 through 2032. With IL-23p19 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IL-23p19 Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global IL-23p19 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IL-23p19 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IL-23p19 Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IL-23p19 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IL-23p19 Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of IL-23p19 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global IL-23p19 Inhibitors market?
What factors are driving IL-23p19 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IL-23p19 Inhibitors market opportunities vary by end market size?
How does IL-23p19 Inhibitors break out by Type, by Application?
IL-23p19 inhibitors are a class of drugs that work by inhibiting the biological activity of Interleukin-23 (IL-23). IL-23 is a cytokine composed of two subunits, p40 and p19, of which p19 is the specific subunit of IL-23?The mechanism of action of IL-23p19 inhibitors is to prevent IL-23 from binding to its receptor by specifically binding to the p19 subunit of IL-23, thereby disrupting IL-23-mediated signaling pathways and reducing the production of inflammatory factors, such as IL-17, IL-22 and GM-CSF. These factors play an important role in chronic inflammatory diseases.
United States market for IL-23p19 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IL-23p19 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IL-23p19 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IL-23p19 Inhibitors players cover Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?IL-23p19 Inhibitors Industry Forecast? looks at past sales and reviews total world IL-23p19 Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected IL-23p19 Inhibitors sales for 2026 through 2032. With IL-23p19 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IL-23p19 Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global IL-23p19 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IL-23p19 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IL-23p19 Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IL-23p19 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IL-23p19 Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of IL-23p19 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100mg/mL
- 75mg/mL
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- AbbVie
- Merck Sharp & Dohme Corp.
- Innovent Biologics (Suzhou) Co. Ltd.
- Johnson & Johnson
What is the 10-year outlook for the global IL-23p19 Inhibitors market?
What factors are driving IL-23p19 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IL-23p19 Inhibitors market opportunities vary by end market size?
How does IL-23p19 Inhibitors break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IL-23p19 Inhibitors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IL-23p19 Inhibitors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IL-23p19 Inhibitors by Country/Region, 2021, 2025 & 2032
2.2 IL-23p19 Inhibitors Segment by Type
2.2.1 100mg/mL
2.2.2 75mg/mL
2.2.3 IL-23p19 Inhibitors Sales by Type
2.2.3.1 Global IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
2.2.3.2 Global IL-23p19 Inhibitors Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IL-23p19 Inhibitors Sale Price by Type (2021-2026)
2.3 IL-23p19 Inhibitors Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 IL-23p19 Inhibitors Sales by Application
2.3.4.1 Global IL-23p19 Inhibitors Sale Market Share by Application (2021-2026)
2.3.4.2 Global IL-23p19 Inhibitors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global IL-23p19 Inhibitors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IL-23p19 Inhibitors Breakdown Data by Company
3.1.1 Global IL-23p19 Inhibitors Annual Sales by Company (2021-2026)
3.1.2 Global IL-23p19 Inhibitors Sales Market Share by Company (2021-2026)
3.2 Global IL-23p19 Inhibitors Annual Revenue by Company (2021-2026)
3.2.1 Global IL-23p19 Inhibitors Revenue by Company (2021-2026)
3.2.2 Global IL-23p19 Inhibitors Revenue Market Share by Company (2021-2026)
3.3 Global IL-23p19 Inhibitors Sale Price by Company
3.4 Key Manufacturers IL-23p19 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IL-23p19 Inhibitors Product Location Distribution
3.4.2 Players IL-23p19 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IL-23P19 INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic IL-23p19 Inhibitors Market Size by Geographic Region (2021-2026)
4.1.1 Global IL-23p19 Inhibitors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IL-23p19 Inhibitors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IL-23p19 Inhibitors Market Size by Country/Region (2021-2026)
4.2.1 Global IL-23p19 Inhibitors Annual Sales by Country/Region (2021-2026)
4.2.2 Global IL-23p19 Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas IL-23p19 Inhibitors Sales Growth
4.4 APAC IL-23p19 Inhibitors Sales Growth
4.5 Europe IL-23p19 Inhibitors Sales Growth
4.6 Middle East & Africa IL-23p19 Inhibitors Sales Growth
5 AMERICAS
5.1 Americas IL-23p19 Inhibitors Sales by Country
5.1.1 Americas IL-23p19 Inhibitors Sales by Country (2021-2026)
5.1.2 Americas IL-23p19 Inhibitors Revenue by Country (2021-2026)
5.2 Americas IL-23p19 Inhibitors Sales by Type (2021-2026)
5.3 Americas IL-23p19 Inhibitors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IL-23p19 Inhibitors Sales by Region
6.1.1 APAC IL-23p19 Inhibitors Sales by Region (2021-2026)
6.1.2 APAC IL-23p19 Inhibitors Revenue by Region (2021-2026)
6.2 APAC IL-23p19 Inhibitors Sales by Type (2021-2026)
6.3 APAC IL-23p19 Inhibitors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IL-23p19 Inhibitors by Country
7.1.1 Europe IL-23p19 Inhibitors Sales by Country (2021-2026)
7.1.2 Europe IL-23p19 Inhibitors Revenue by Country (2021-2026)
7.2 Europe IL-23p19 Inhibitors Sales by Type (2021-2026)
7.3 Europe IL-23p19 Inhibitors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IL-23p19 Inhibitors by Country
8.1.1 Middle East & Africa IL-23p19 Inhibitors Sales by Country (2021-2026)
8.1.2 Middle East & Africa IL-23p19 Inhibitors Revenue by Country (2021-2026)
8.2 Middle East & Africa IL-23p19 Inhibitors Sales by Type (2021-2026)
8.3 Middle East & Africa IL-23p19 Inhibitors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IL-23p19 Inhibitors
10.3 Manufacturing Process Analysis of IL-23p19 Inhibitors
10.4 Industry Chain Structure of IL-23p19 Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IL-23p19 Inhibitors Distributors
11.3 IL-23p19 Inhibitors Customer
12 WORLD FORECAST REVIEW FOR IL-23P19 INHIBITORS BY GEOGRAPHIC REGION
12.1 Global IL-23p19 Inhibitors Market Size Forecast by Region
12.1.1 Global IL-23p19 Inhibitors Forecast by Region (2027-2032)
12.1.2 Global IL-23p19 Inhibitors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IL-23p19 Inhibitors Forecast by Type (2027-2032)
12.7 Global IL-23p19 Inhibitors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly IL-23p19 Inhibitors Product Portfolios and Specifications
13.1.3 Eli Lilly IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie IL-23p19 Inhibitors Product Portfolios and Specifications
13.2.3 AbbVie IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Merck Sharp & Dohme Corp.
13.3.1 Merck Sharp & Dohme Corp. Company Information
13.3.2 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolios and Specifications
13.3.3 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Sharp & Dohme Corp. Main Business Overview
13.3.5 Merck Sharp & Dohme Corp. Latest Developments
13.4 Innovent Biologics (Suzhou) Co. Ltd.
13.4.1 Innovent Biologics (Suzhou) Co. Ltd. Company Information
13.4.2 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolios and Specifications
13.4.3 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Innovent Biologics (Suzhou) Co. Ltd. Main Business Overview
13.4.5 Innovent Biologics (Suzhou) Co. Ltd. Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson IL-23p19 Inhibitors Product Portfolios and Specifications
13.5.3 Johnson & Johnson IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IL-23p19 Inhibitors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IL-23p19 Inhibitors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IL-23p19 Inhibitors by Country/Region, 2021, 2025 & 2032
2.2 IL-23p19 Inhibitors Segment by Type
2.2.1 100mg/mL
2.2.2 75mg/mL
2.2.3 IL-23p19 Inhibitors Sales by Type
2.2.3.1 Global IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
2.2.3.2 Global IL-23p19 Inhibitors Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IL-23p19 Inhibitors Sale Price by Type (2021-2026)
2.3 IL-23p19 Inhibitors Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 IL-23p19 Inhibitors Sales by Application
2.3.4.1 Global IL-23p19 Inhibitors Sale Market Share by Application (2021-2026)
2.3.4.2 Global IL-23p19 Inhibitors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global IL-23p19 Inhibitors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IL-23p19 Inhibitors Breakdown Data by Company
3.1.1 Global IL-23p19 Inhibitors Annual Sales by Company (2021-2026)
3.1.2 Global IL-23p19 Inhibitors Sales Market Share by Company (2021-2026)
3.2 Global IL-23p19 Inhibitors Annual Revenue by Company (2021-2026)
3.2.1 Global IL-23p19 Inhibitors Revenue by Company (2021-2026)
3.2.2 Global IL-23p19 Inhibitors Revenue Market Share by Company (2021-2026)
3.3 Global IL-23p19 Inhibitors Sale Price by Company
3.4 Key Manufacturers IL-23p19 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IL-23p19 Inhibitors Product Location Distribution
3.4.2 Players IL-23p19 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IL-23P19 INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic IL-23p19 Inhibitors Market Size by Geographic Region (2021-2026)
4.1.1 Global IL-23p19 Inhibitors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IL-23p19 Inhibitors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IL-23p19 Inhibitors Market Size by Country/Region (2021-2026)
4.2.1 Global IL-23p19 Inhibitors Annual Sales by Country/Region (2021-2026)
4.2.2 Global IL-23p19 Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas IL-23p19 Inhibitors Sales Growth
4.4 APAC IL-23p19 Inhibitors Sales Growth
4.5 Europe IL-23p19 Inhibitors Sales Growth
4.6 Middle East & Africa IL-23p19 Inhibitors Sales Growth
5 AMERICAS
5.1 Americas IL-23p19 Inhibitors Sales by Country
5.1.1 Americas IL-23p19 Inhibitors Sales by Country (2021-2026)
5.1.2 Americas IL-23p19 Inhibitors Revenue by Country (2021-2026)
5.2 Americas IL-23p19 Inhibitors Sales by Type (2021-2026)
5.3 Americas IL-23p19 Inhibitors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IL-23p19 Inhibitors Sales by Region
6.1.1 APAC IL-23p19 Inhibitors Sales by Region (2021-2026)
6.1.2 APAC IL-23p19 Inhibitors Revenue by Region (2021-2026)
6.2 APAC IL-23p19 Inhibitors Sales by Type (2021-2026)
6.3 APAC IL-23p19 Inhibitors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IL-23p19 Inhibitors by Country
7.1.1 Europe IL-23p19 Inhibitors Sales by Country (2021-2026)
7.1.2 Europe IL-23p19 Inhibitors Revenue by Country (2021-2026)
7.2 Europe IL-23p19 Inhibitors Sales by Type (2021-2026)
7.3 Europe IL-23p19 Inhibitors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IL-23p19 Inhibitors by Country
8.1.1 Middle East & Africa IL-23p19 Inhibitors Sales by Country (2021-2026)
8.1.2 Middle East & Africa IL-23p19 Inhibitors Revenue by Country (2021-2026)
8.2 Middle East & Africa IL-23p19 Inhibitors Sales by Type (2021-2026)
8.3 Middle East & Africa IL-23p19 Inhibitors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IL-23p19 Inhibitors
10.3 Manufacturing Process Analysis of IL-23p19 Inhibitors
10.4 Industry Chain Structure of IL-23p19 Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IL-23p19 Inhibitors Distributors
11.3 IL-23p19 Inhibitors Customer
12 WORLD FORECAST REVIEW FOR IL-23P19 INHIBITORS BY GEOGRAPHIC REGION
12.1 Global IL-23p19 Inhibitors Market Size Forecast by Region
12.1.1 Global IL-23p19 Inhibitors Forecast by Region (2027-2032)
12.1.2 Global IL-23p19 Inhibitors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IL-23p19 Inhibitors Forecast by Type (2027-2032)
12.7 Global IL-23p19 Inhibitors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly IL-23p19 Inhibitors Product Portfolios and Specifications
13.1.3 Eli Lilly IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie IL-23p19 Inhibitors Product Portfolios and Specifications
13.2.3 AbbVie IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Merck Sharp & Dohme Corp.
13.3.1 Merck Sharp & Dohme Corp. Company Information
13.3.2 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolios and Specifications
13.3.3 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Sharp & Dohme Corp. Main Business Overview
13.3.5 Merck Sharp & Dohme Corp. Latest Developments
13.4 Innovent Biologics (Suzhou) Co. Ltd.
13.4.1 Innovent Biologics (Suzhou) Co. Ltd. Company Information
13.4.2 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolios and Specifications
13.4.3 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Innovent Biologics (Suzhou) Co. Ltd. Main Business Overview
13.4.5 Innovent Biologics (Suzhou) Co. Ltd. Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson IL-23p19 Inhibitors Product Portfolios and Specifications
13.5.3 Johnson & Johnson IL-23p19 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IL-23p19 Inhibitors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IL-23p19 Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100mg/mL
Table 4. Major Players of 75mg/mL
Table 5. Global IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 6. Global IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Table 7. Global IL-23p19 Inhibitors Revenue by Type (2021-2026) & ($ million)
Table 8. Global IL-23p19 Inhibitors Revenue Market Share by Type (2021-2026)
Table 9. Global IL-23p19 Inhibitors Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global IL-23p19 Inhibitors Sale by Application (2021-2026) & (K Units)
Table 11. Global IL-23p19 Inhibitors Sale Market Share by Application (2021-2026)
Table 12. Global IL-23p19 Inhibitors Revenue by Application (2021-2026) & ($ million)
Table 13. Global IL-23p19 Inhibitors Revenue Market Share by Application (2021-2026)
Table 14. Global IL-23p19 Inhibitors Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global IL-23p19 Inhibitors Sales by Company (2021-2026) & (K Units)
Table 16. Global IL-23p19 Inhibitors Sales Market Share by Company (2021-2026)
Table 17. Global IL-23p19 Inhibitors Revenue by Company (2021-2026) & ($ millions)
Table 18. Global IL-23p19 Inhibitors Revenue Market Share by Company (2021-2026)
Table 19. Global IL-23p19 Inhibitors Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers IL-23p19 Inhibitors Producing Area Distribution and Sales Area
Table 21. Players IL-23p19 Inhibitors Products Offered
Table 22. IL-23p19 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global IL-23p19 Inhibitors Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global IL-23p19 Inhibitors Sales Market Share Geographic Region (2021-2026)
Table 27. Global IL-23p19 Inhibitors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global IL-23p19 Inhibitors Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global IL-23p19 Inhibitors Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global IL-23p19 Inhibitors Sales Market Share by Country/Region (2021-2026)
Table 31. Global IL-23p19 Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global IL-23p19 Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 34. Americas IL-23p19 Inhibitors Sales Market Share by Country (2021-2026)
Table 35. Americas IL-23p19 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 37. Americas IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 38. APAC IL-23p19 Inhibitors Sales by Region (2021-2026) & (K Units)
Table 39. APAC IL-23p19 Inhibitors Sales Market Share by Region (2021-2026)
Table 40. APAC IL-23p19 Inhibitors Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 42. APAC IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 43. Europe IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 44. Europe IL-23p19 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 46. Europe IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa IL-23p19 Inhibitors Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of IL-23p19 Inhibitors
Table 52. Key Market Challenges & Risks of IL-23p19 Inhibitors
Table 53. Key Industry Trends of IL-23p19 Inhibitors
Table 54. IL-23p19 Inhibitors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. IL-23p19 Inhibitors Distributors List
Table 57. IL-23p19 Inhibitors Customer List
Table 58. Global IL-23p19 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global IL-23p19 Inhibitors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas IL-23p19 Inhibitors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC IL-23p19 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC IL-23p19 Inhibitors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe IL-23p19 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa IL-23p19 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global IL-23p19 Inhibitors Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global IL-23p19 Inhibitors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global IL-23p19 Inhibitors Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global IL-23p19 Inhibitors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Eli Lilly Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 73. Eli Lilly IL-23p19 Inhibitors Product Portfolios and Specifications
Table 74. Eli Lilly IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Eli Lilly Main Business
Table 76. Eli Lilly Latest Developments
Table 77. AbbVie Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 78. AbbVie IL-23p19 Inhibitors Product Portfolios and Specifications
Table 79. AbbVie IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AbbVie Main Business
Table 81. AbbVie Latest Developments
Table 82. Merck Sharp & Dohme Corp. Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolios and Specifications
Table 84. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Sharp & Dohme Corp. Main Business
Table 86. Merck Sharp & Dohme Corp. Latest Developments
Table 87. Innovent Biologics (Suzhou) Co. Ltd. Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolios and Specifications
Table 89. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Innovent Biologics (Suzhou) Co. Ltd. Main Business
Table 91. Innovent Biologics (Suzhou) Co. Ltd. Latest Developments
Table 92. Johnson & Johnson Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson IL-23p19 Inhibitors Product Portfolios and Specifications
Table 94. Johnson & Johnson IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 1. IL-23p19 Inhibitors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IL-23p19 Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100mg/mL
Table 4. Major Players of 75mg/mL
Table 5. Global IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 6. Global IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Table 7. Global IL-23p19 Inhibitors Revenue by Type (2021-2026) & ($ million)
Table 8. Global IL-23p19 Inhibitors Revenue Market Share by Type (2021-2026)
Table 9. Global IL-23p19 Inhibitors Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global IL-23p19 Inhibitors Sale by Application (2021-2026) & (K Units)
Table 11. Global IL-23p19 Inhibitors Sale Market Share by Application (2021-2026)
Table 12. Global IL-23p19 Inhibitors Revenue by Application (2021-2026) & ($ million)
Table 13. Global IL-23p19 Inhibitors Revenue Market Share by Application (2021-2026)
Table 14. Global IL-23p19 Inhibitors Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global IL-23p19 Inhibitors Sales by Company (2021-2026) & (K Units)
Table 16. Global IL-23p19 Inhibitors Sales Market Share by Company (2021-2026)
Table 17. Global IL-23p19 Inhibitors Revenue by Company (2021-2026) & ($ millions)
Table 18. Global IL-23p19 Inhibitors Revenue Market Share by Company (2021-2026)
Table 19. Global IL-23p19 Inhibitors Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers IL-23p19 Inhibitors Producing Area Distribution and Sales Area
Table 21. Players IL-23p19 Inhibitors Products Offered
Table 22. IL-23p19 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global IL-23p19 Inhibitors Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global IL-23p19 Inhibitors Sales Market Share Geographic Region (2021-2026)
Table 27. Global IL-23p19 Inhibitors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global IL-23p19 Inhibitors Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global IL-23p19 Inhibitors Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global IL-23p19 Inhibitors Sales Market Share by Country/Region (2021-2026)
Table 31. Global IL-23p19 Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global IL-23p19 Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 34. Americas IL-23p19 Inhibitors Sales Market Share by Country (2021-2026)
Table 35. Americas IL-23p19 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 37. Americas IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 38. APAC IL-23p19 Inhibitors Sales by Region (2021-2026) & (K Units)
Table 39. APAC IL-23p19 Inhibitors Sales Market Share by Region (2021-2026)
Table 40. APAC IL-23p19 Inhibitors Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 42. APAC IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 43. Europe IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 44. Europe IL-23p19 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 46. Europe IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa IL-23p19 Inhibitors Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of IL-23p19 Inhibitors
Table 52. Key Market Challenges & Risks of IL-23p19 Inhibitors
Table 53. Key Industry Trends of IL-23p19 Inhibitors
Table 54. IL-23p19 Inhibitors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. IL-23p19 Inhibitors Distributors List
Table 57. IL-23p19 Inhibitors Customer List
Table 58. Global IL-23p19 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global IL-23p19 Inhibitors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas IL-23p19 Inhibitors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC IL-23p19 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC IL-23p19 Inhibitors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe IL-23p19 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa IL-23p19 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global IL-23p19 Inhibitors Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global IL-23p19 Inhibitors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global IL-23p19 Inhibitors Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global IL-23p19 Inhibitors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Eli Lilly Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 73. Eli Lilly IL-23p19 Inhibitors Product Portfolios and Specifications
Table 74. Eli Lilly IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Eli Lilly Main Business
Table 76. Eli Lilly Latest Developments
Table 77. AbbVie Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 78. AbbVie IL-23p19 Inhibitors Product Portfolios and Specifications
Table 79. AbbVie IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AbbVie Main Business
Table 81. AbbVie Latest Developments
Table 82. Merck Sharp & Dohme Corp. Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolios and Specifications
Table 84. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Sharp & Dohme Corp. Main Business
Table 86. Merck Sharp & Dohme Corp. Latest Developments
Table 87. Innovent Biologics (Suzhou) Co. Ltd. Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolios and Specifications
Table 89. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Innovent Biologics (Suzhou) Co. Ltd. Main Business
Table 91. Innovent Biologics (Suzhou) Co. Ltd. Latest Developments
Table 92. Johnson & Johnson Basic Information, IL-23p19 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson IL-23p19 Inhibitors Product Portfolios and Specifications
Table 94. Johnson & Johnson IL-23p19 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
LIST OF FIGURES
Figure 1. Picture of IL-23p19 Inhibitors
Figure 2. IL-23p19 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IL-23p19 Inhibitors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global IL-23p19 Inhibitors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IL-23p19 Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IL-23p19 Inhibitors Sales Market Share by Country/Region (2025)
Figure 10. IL-23p19 Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100mg/mL
Figure 12. Product Picture of 75mg/mL
Figure 13. Global IL-23p19 Inhibitors Sales Market Share by Type in 2026
Figure 14. Global IL-23p19 Inhibitors Revenue Market Share by Type (2021-2026)
Figure 15. IL-23p19 Inhibitors Consumed in Hospital
Figure 16. Global IL-23p19 Inhibitors Market: Hospital (2021-2026) & (K Units)
Figure 17. IL-23p19 Inhibitors Consumed in Clinic
Figure 18. Global IL-23p19 Inhibitors Market: Clinic (2021-2026) & (K Units)
Figure 19. IL-23p19 Inhibitors Consumed in Others
Figure 20. Global IL-23p19 Inhibitors Market: Others (2021-2026) & (K Units)
Figure 21. Global IL-23p19 Inhibitors Sale Market Share by Application (2025)
Figure 22. Global IL-23p19 Inhibitors Revenue Market Share by Application in 2026
Figure 23. IL-23p19 Inhibitors Sales by Company in 2026 (K Units)
Figure 24. Global IL-23p19 Inhibitors Sales Market Share by Company in 2026
Figure 25. IL-23p19 Inhibitors Revenue by Company in 2026 ($ millions)
Figure 26. Global IL-23p19 Inhibitors Revenue Market Share by Company in 2026
Figure 27. Global IL-23p19 Inhibitors Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global IL-23p19 Inhibitors Revenue Market Share by Geographic Region in 2026
Figure 29. Americas IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 30. Americas IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 31. APAC IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 32. APAC IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 33. Europe IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 34. Europe IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 37. Americas IL-23p19 Inhibitors Sales Market Share by Country in 2026
Figure 38. Americas IL-23p19 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 39. Americas IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 40. Americas IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 41. United States IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC IL-23p19 Inhibitors Sales Market Share by Region in 2026
Figure 46. APAC IL-23p19 Inhibitors Revenue Market Share by Region (2021-2026)
Figure 47. APAC IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 48. APAC IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 49. China IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 53. India IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe IL-23p19 Inhibitors Sales Market Share by Country in 2026
Figure 57. Europe IL-23p19 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 58. Europe IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 59. Europe IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 60. Germany IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 61. France IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 62. UK IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa IL-23p19 Inhibitors Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 68. Egypt IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of IL-23p19 Inhibitors in 2026
Figure 74. Manufacturing Process Analysis of IL-23p19 Inhibitors
Figure 75. Industry Chain Structure of IL-23p19 Inhibitors
Figure 76. Channels of Distribution
Figure 77. Global IL-23p19 Inhibitors Sales Market Forecast by Region (2027-2032)
Figure 78. Global IL-23p19 Inhibitors Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global IL-23p19 Inhibitors Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global IL-23p19 Inhibitors Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global IL-23p19 Inhibitors Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global IL-23p19 Inhibitors Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of IL-23p19 Inhibitors
Figure 2. IL-23p19 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IL-23p19 Inhibitors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global IL-23p19 Inhibitors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IL-23p19 Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IL-23p19 Inhibitors Sales Market Share by Country/Region (2025)
Figure 10. IL-23p19 Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100mg/mL
Figure 12. Product Picture of 75mg/mL
Figure 13. Global IL-23p19 Inhibitors Sales Market Share by Type in 2026
Figure 14. Global IL-23p19 Inhibitors Revenue Market Share by Type (2021-2026)
Figure 15. IL-23p19 Inhibitors Consumed in Hospital
Figure 16. Global IL-23p19 Inhibitors Market: Hospital (2021-2026) & (K Units)
Figure 17. IL-23p19 Inhibitors Consumed in Clinic
Figure 18. Global IL-23p19 Inhibitors Market: Clinic (2021-2026) & (K Units)
Figure 19. IL-23p19 Inhibitors Consumed in Others
Figure 20. Global IL-23p19 Inhibitors Market: Others (2021-2026) & (K Units)
Figure 21. Global IL-23p19 Inhibitors Sale Market Share by Application (2025)
Figure 22. Global IL-23p19 Inhibitors Revenue Market Share by Application in 2026
Figure 23. IL-23p19 Inhibitors Sales by Company in 2026 (K Units)
Figure 24. Global IL-23p19 Inhibitors Sales Market Share by Company in 2026
Figure 25. IL-23p19 Inhibitors Revenue by Company in 2026 ($ millions)
Figure 26. Global IL-23p19 Inhibitors Revenue Market Share by Company in 2026
Figure 27. Global IL-23p19 Inhibitors Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global IL-23p19 Inhibitors Revenue Market Share by Geographic Region in 2026
Figure 29. Americas IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 30. Americas IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 31. APAC IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 32. APAC IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 33. Europe IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 34. Europe IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa IL-23p19 Inhibitors Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa IL-23p19 Inhibitors Revenue 2021-2026 ($ millions)
Figure 37. Americas IL-23p19 Inhibitors Sales Market Share by Country in 2026
Figure 38. Americas IL-23p19 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 39. Americas IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 40. Americas IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 41. United States IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC IL-23p19 Inhibitors Sales Market Share by Region in 2026
Figure 46. APAC IL-23p19 Inhibitors Revenue Market Share by Region (2021-2026)
Figure 47. APAC IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 48. APAC IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 49. China IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 53. India IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe IL-23p19 Inhibitors Sales Market Share by Country in 2026
Figure 57. Europe IL-23p19 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 58. Europe IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 59. Europe IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 60. Germany IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 61. France IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 62. UK IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa IL-23p19 Inhibitors Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa IL-23p19 Inhibitors Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa IL-23p19 Inhibitors Sales Market Share by Application (2021-2026)
Figure 68. Egypt IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries IL-23p19 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of IL-23p19 Inhibitors in 2026
Figure 74. Manufacturing Process Analysis of IL-23p19 Inhibitors
Figure 75. Industry Chain Structure of IL-23p19 Inhibitors
Figure 76. Channels of Distribution
Figure 77. Global IL-23p19 Inhibitors Sales Market Forecast by Region (2027-2032)
Figure 78. Global IL-23p19 Inhibitors Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global IL-23p19 Inhibitors Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global IL-23p19 Inhibitors Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global IL-23p19 Inhibitors Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global IL-23p19 Inhibitors Revenue Market Share Forecast by Application (2027-2032)
